Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Dialogues in Clinical Neuroscience
|
August 3, 2005
Interpreting the association between cannabis use and increased risk for schizophrenia
Mark Weiser, Shlomo Noy
Schizophrenia Research
|
June 21, 2005
Comments on risk for schizophrenia
Mark Weiser, Michael Davidson, Shlomo Noy
Dialogues in Clinical Neuroscience
|
August 3, 2005
The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis
Michael Davidson, Asaf Caspi, Shlomo Noy
Dialogues in Clinical Neuroscience
|
October 29, 2011
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?
Ramit Ravona-Springer, Michael Davidson, Shlomo Noy
CNS Spectrums
|
January 1, 2004
The role of cardiovascular risk factors in Alzheimer's disease
Ramit Ravona-Springer, Michael Davidson, Shlomo Noy
American Journal of Medical Genetics
|
November 29, 2002
Clinical characteristics of adolescents later hospitalized for schizophrenia
Mark Weiser, Haim Y Knobler, Shlomo Noy, et al.
International Journal of Geriatric Psychiatry
|
May 8, 2002
The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients
Michal Schnaider Beeri, Perla Werner, Michael Davidson, et al.
Archives of Gerontology and Geriatrics
|
December 31, 2003
Measuring the suffering of end-stage dementia: reliability and validity of the Mini-Suffering State Examination
Bechor Z Aminoff, Elena Purits, Shlomo Noy, et al.
Alzheimer Disease and Associated Disorders
|
June 1, 2002
Economic cost of Alzheimer disease in Israel
Michal Schnaider Beeri, Perla Werner, Zvi Adar, et al.
Journal of Palliative Medicine
|
May 14, 2005
Describing the social environment of elderly persons at the time of death
Perla Werner, Ehud Miron, Michal Schnaider Beeri, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Dialogues in Clinical Neuroscience
|
August 3, 2005
Interpreting the association between cannabis use and increased risk for schizophrenia
Mark Weiser, Shlomo Noy
Schizophrenia Research
|
June 21, 2005
Comments on risk for schizophrenia
Mark Weiser, Michael Davidson, Shlomo Noy
Dialogues in Clinical Neuroscience
|
August 3, 2005
The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis
Michael Davidson, Asaf Caspi, Shlomo Noy
Dialogues in Clinical Neuroscience
|
October 29, 2011
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?
Ramit Ravona-Springer, Michael Davidson, Shlomo Noy
CNS Spectrums
|
January 1, 2004
The role of cardiovascular risk factors in Alzheimer's disease
Ramit Ravona-Springer, Michael Davidson, Shlomo Noy
American Journal of Medical Genetics
|
November 29, 2002
Clinical characteristics of adolescents later hospitalized for schizophrenia
Mark Weiser, Haim Y Knobler, Shlomo Noy, et al.
International Journal of Geriatric Psychiatry
|
May 8, 2002
The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients
Michal Schnaider Beeri, Perla Werner, Michael Davidson, et al.
Archives of Gerontology and Geriatrics
|
December 31, 2003
Measuring the suffering of end-stage dementia: reliability and validity of the Mini-Suffering State Examination
Bechor Z Aminoff, Elena Purits, Shlomo Noy, et al.
Alzheimer Disease and Associated Disorders
|
June 1, 2002
Economic cost of Alzheimer disease in Israel
Michal Schnaider Beeri, Perla Werner, Zvi Adar, et al.
Journal of Palliative Medicine
|
May 14, 2005
Describing the social environment of elderly persons at the time of death
Perla Werner, Ehud Miron, Michal Schnaider Beeri, et al.
Page
of 3